TESTOSTERONE RECOVERY PROFILES AFTER CESSATION OF ANDROGEN DEPRIVATION THERAPY (ADT)

被引：0
|
作者：
Miranda, E. [1 ]
Schofield, E. [1 ]
Jenkins, L. [1 ]
Nelson, C. [1 ]
Mulhall, J. [1 ]
机构：
[1] MSKCC, New York, NY USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2018年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
036
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Prolonged hypogonadism after cessation of androgen deprivation therapy for prostate cancer
    Rodriguez-Rubio Cortadellas, Federico I.
    Jimenez Romero, Miguel E.
    Gonzalez Moreno, Delfin
    Novalbos Ruiz, Jose P.
    Garrido Insua, Sofia
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (07): : 747 - 754
  • [32] Audit of androgen deprivation therapy (ADT) register in Auckland region
    Zargar, H.
    Beaven, T.
    BJU INTERNATIONAL, 2006, 97 : 1 - 1
  • [33] Androgen deprivation therapy (ADT) for node postive prostate cancer
    Wong, Y.
    Freedland, S.
    Hudes, G.
    Mitra, N.
    Montagnet, C.
    Armstrong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] ORGASM IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Mazzola, C.
    Teloken, P. E.
    Matsuhsita, K.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S50 - S50
  • [35] Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate
    Ross, Robert W.
    Xie, Wanling
    Regan, Meredith M.
    Pomerantz, Mark
    Nakabayashi, Mari
    Daskivich, Timothy J.
    Sartor, Oliver
    Taplin, Mary-Ellen
    Kantoff, Philip W.
    Oh, William K.
    CANCER, 2008, 112 (06) : 1247 - 1253
  • [36] MUSCULOSKELETAL HEALTH IN ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Zigoura, E.
    Veronese, N.
    Floris, A.
    Schiavone, C.
    Campodonico, F.
    Ennas, M.
    Pilotto, A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S282 - S282
  • [37] Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT)
    Shah, Sarthak
    Pepin, Abigail
    Forsthoefel, Matthew
    Burlile, Jessica
    Collins, Brian T.
    Simeng, Suy
    Aghdam, Nima
    Collins, Sean
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [38] Prospective NIS study on androgen deprivation therapy (ADT) in prostate cancer patients with special consideration of testosterone levels
    Rexer, H.
    Koenig, F.
    Boegemann, M.
    UROLOGIE, 2024, 63 (10): : 1083 - 1084
  • [39] Neuroendocrine prostate cancer (NEPC) after androgen deprivation therapy (ADT): Clinical characteristics.
    Akhtar, Naveed Hassan
    Beltran, Himisha
    Afzal, Muhammad Zubair
    Ecker, Caryn
    Nanus, David M.
    Tagawa, Scott T.
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [40] Testosterone-guided schedule of androgen deprivation therapy (ADT) as an alternative to a fixed schedule in management of prostate cancer.
    Niraula, Saroj
    Badillo, Francisco Emilio Vera
    Templeton, Arnoud J.
    Dodd, Anna
    Nugent, Zoann
    Tannock, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345